ResearcherNew York UniversityActive in the last 2 years

Michael Shusterman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2899-7714; OpenAlex author ID A5018910790. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. Co-author DOI 10.1111/cas.70320 ↗
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. Co-author DOI 10.1038/s41698-025-00848-2 ↗
The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer. Co-author DOI 10.1007/s12029-019-00316-8 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jessica L. Widmer · 2 shared papers, 2025–2026 · strength 0.45
- Paper Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. DOI 10.1111/cas.70320 ↗
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
John Allendorf · 2 shared papers, 2025–2026 · strength 0.45
- Paper Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. DOI 10.1111/cas.70320 ↗
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Yao‐Zhong Liu · 1 shared paper, 2026 · strength 0.24
- Paper Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. DOI 10.1111/cas.70320 ↗
Xiaofei Zhang · 1 shared paper, 2026 · strength 0.24
- Paper Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. DOI 10.1111/cas.70320 ↗
Danting Li · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Venu Gopal Pillarisetty · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Xiaofei Zhang · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Yaozhong Liu · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Jennifer W. Chuy · 1 shared paper, 2020 · strength 0.11
- Paper The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced … DOI 10.1007/s12029-019-00316-8 ↗
Andreas Kaubisch · 1 shared paper, 2020 · strength 0.11
- Paper The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced … DOI 10.1007/s12029-019-00316-8 ↗
Justin Tang · 1 shared paper, 2020 · strength 0.11
- Paper The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced … DOI 10.1007/s12029-019-00316-8 ↗
Sanjay Goel · 1 shared paper, 2020 · strength 0.11
- Paper The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced … DOI 10.1007/s12029-019-00316-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.